{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Multisystem Inflammatory Syndrome in Children: A Complication of COVID-19

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Choose evidence-based guidelines for assessing a child who might have MIS-C following exposure to COVID-19.
  2. Select the appropriate information to share with parents of children who have MIS-C.
  3. Recognize the risk among children for developing COVID-19 and subsequent MIS-C.
  4. Identify the current recommendations for administering COVID-19 vaccines to children.

Learning Outcomes

Nurses will demonstrate competency in clinical reasoning regarding the assessment and evidence-based treatment of multisystem inflammatory syndrome in children (MIS-C) by achieving a minimum score of 70% on the outcomes based posttest.
Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: N1021A
Published: Oct 2021
Expires: 9/6/2024
Collections: CESaver
Sources: Nursing2024
Required Passing Score: 8/10 (80%)
Authors: Andrew Greenway, MSN, RN, CCRN, AACNS-AG; Holly MacKlay, MS, MA, RN, FNP-BC, CCRN-K; Kevin Xuereb, MSN, MSED, RN, CCRN, AACNS-AG; Linda Gibbons, MS, RN, NEA-BC